Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory Glaucoma

Status unconfirmed · Not applicable

Conditions studied: Glaucoma

In brief

Prospective, multi-center, single-arm clinical trial to evaluate the safety and effectiveness of the Glaukos® Trabecular Micro-Bypass System Model iS3 (three stents per study eye) in subjects with refractory glaucoma.

Key facts

Study ID

NCT03639870

Run by

Glaukos Corporation

People needed

65

Starts

2018-07-10

Expected to finish

2021-09-01

Last updated by the study team

2021-04-23

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of refractory open-angle glaucoma (including pigmentary and pseudoexfoliative glaucoma) that is uncontrolled despite medical therapy and/or prior conventional incisional intraocular glaucoma surgeries.
• Phakic or pseudophakic.
• Males or females, 45 years of age or older.

You may not qualify if…

• Traumatic, uveitic, neovascular, or angle-closure; or glaucoma associated with vascular disorders.
• Active corneal inflammation or edema.
• Retinal disorders not associated with glaucoma.

Where it is running

• Glaucoma Associates of Tx — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.